Early development of infants with neurofibromatosis type 1: a case series

被引:18
|
作者
Kolesnik, Anna May [1 ,2 ]
Jones, Emily Jane Harrison [1 ,2 ]
Garg, Shruti [3 ,4 ]
Green, Jonathan [3 ,4 ]
Charman, Tony [5 ]
Johnson, Mark Henry [1 ,2 ]
机构
[1] Birkbeck Univ London, Ctr Brain & Cognit Dev, Malet St, London WC1E 7HX, England
[2] Birkbeck Univ London, Dept Psychol, Malet St, London WC1E 7HX, England
[3] Univ Manchester, Manchester Acad, Neurosci & Expt Psychol, Hlth Sci Ctr, Manchester, Lancs, England
[4] Cent Manchester Univ Hosp NHS Fdn, Royal Manchester Childrens Hosp, Manchester, Lancs, England
[5] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England
来源
MOLECULAR AUTISM | 2017年 / 8卷
关键词
NF1; Infant; Translational neurodevelopment; Autism; Prospective longitudinal; Adaptive functioning; Cognition; Sensory processing; Social engagement; Development; AUTISM SPECTRUM DISORDER; YOUNG-CHILDREN; HIGH-RISK; COGNITIVE DYSFUNCTION; 6-MONTH-OLD INFANTS; LEARNING-DEFICITS; MOUSE MODEL; PREVALENCE; ATTENTION; TEMPERAMENT;
D O I
10.1186/s13229-017-0178-0
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Prospective studies of infants at familial risk for autism spectrum disorder (ASD) have yielded insights into the earliest signs of the disorder but represent heterogeneous samples of unclear aetiology. Complementing this approach by studying cohorts of infants with monogenic syndromes associated with high rates of ASD offers the opportunity to elucidate the factors that lead to ASD. Methods: We present the first report from a prospective study of ten 10-month-old infants with neurofibromatosis type 1 (NF1), a monogenic disorder with high prevalence of ASD or ASD symptomatology. We compared data from infants with NF1 to a large cohort of infants at familial risk for ASD, separated by outcome at age 3 of ASD (n = 34), atypical development (n = 44), or typical development (n = 89), and low-risk controls (n = 75). Domains assessed at 10 months by parent report and examiner observation include cognitive and adaptive function, sensory processing, social engagement, and temperament. Results: Infants with NF1 showed striking impairments in motor functioning relative to low-risk infants; this pattern was seen in infants with later ASD from the familial cohort (HR-ASD). Both infants with NF1 and the HR-ASD group showed communication delays relative to low-risk infants. Conclusions: Ten-month-old infants with NF1 show a range of developmental difficulties that were particularly striking in motor and communication domains. As with HR-ASD infants, social skills at this age were not notably impaired. This is some of the first information on early neurodevelopment in NF1. Strong inferences are limited by the sample size, but the findings suggest implications for early comparative developmental science and highlight motor functioning as an important domain to inform the development of relevant animal models. The findings have clinical implications in indicating an important focus for early surveillance and remediation in this early diagnosed genetic disorder.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Early development of infants with neurofibromatosis type 1: a case series
    Anna May Kolesnik
    Emily Jane Harrison Jones
    Shruti Garg
    Jonathan Green
    Tony Charman
    Mark Henry Johnson
    Molecular Autism, 8
  • [2] Early Developmental Trajectories in Infants With Neurofibromatosis 1
    Garg, Shruti
    Wan, Ming Wai
    Begum-Ali, Jannath
    Kolesnik-Taylor, Anna
    Green, Jonathan
    Johnson, Mark H.
    Jones, Emily
    EDEN-STAARS Team
    FRONTIERS IN PSYCHOLOGY, 2022, 13
  • [3] Characterization of early communicative behavior in mouse models of neurofibromatosis type 1
    Maloney, Susan E.
    Chandler, Krystal C.
    Anastasaki, Corina
    Rieger, Michael A.
    Gutmann, David H.
    Dougherty, Joseph D.
    AUTISM RESEARCH, 2018, 11 (01) : 44 - 58
  • [4] Disrupted visual attention relates to cognitive development in infants with Neurofibromatosis Type 1
    Begum-Ali, Jannath
    Mason, Luke
    Charman, Tony
    Johnson, Mark H.
    Green, Jonathan
    Garg, Shruti
    Jones, Emily J. H.
    JOURNAL OF NEURODEVELOPMENTAL DISORDERS, 2025, 17 (01)
  • [5] Early Development of Infants with Turner Syndrome
    Pretzel, Rebecca Edmondson
    Knickmeyer, Rebecca C.
    DeRamus, Margaret
    Duquette, Peter
    Okoniewski, Katherine C.
    Reinhartsen, Debra B.
    Cornea, Emil
    Gilmore, John H.
    Goldman, Barbara D.
    Davenport, Marsha L.
    Hooper, Stephen R.
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2020, 41 (06) : 470 - 479
  • [6] Cognitive and behavioral problems in children with neurofibromatosis type 1: challenges and future directions
    Schwetye, Katherine E.
    Gutmann, David H.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (10) : 1139 - 1152
  • [7] Developmental trajectories in infants and pre-school children with Neurofibromatosis 1
    Slevin, Hannah
    Kehinde, Fiona
    Begum-Ali, Jannath
    Ellis, Ceri
    Burkitt-Wright, Emma
    Green, Jonathan
    Johnson, Mark H.
    Pasco, Greg
    Charman, Tony
    Jones, Emily J. H.
    Garg, Shruti
    Agyapong, Mary
    Bazelmans, Tessel
    Dafner, Leila
    Ersoy, Mutluhan
    Gliga, Teodora
    Goodwin, Amy
    Haartsen, Rianne
    Halkola, Hanna
    Hendry, Alexandra
    Holman, Rebecca
    Kalwarowsky, Sarah
    Lloyd-Fox, Sarah
    Mason, Luke
    Narvekar, Nisha
    Pirazzoli, Laura
    Taylor, Chloe
    Vassallo, Grace
    Eelloo, Judith
    Evans, D. Gareth
    West, Siobhan
    Hupton, Eileen
    Robinson, Louise
    Lakhani, Neeta
    Wilson, Brian
    Osio, Deborah
    Shaw-Smith, Charles
    Canham, Natalie
    Sharif, Saba
    MOLECULAR AUTISM, 2024, 15 (01):
  • [8] COEXISTENCE OF AUTISM WITH NEUROFIBROMATOSIS TYPE 1
    Harchaoui, Hakim
    Samih, Majda
    Ahami, Ahmed Omar Touhami
    ACTA NEUROPSYCHOLOGICA, 2021, 19 (01) : 121 - 126
  • [9] Neurofibromatosis Type 1 and Autism Spectrum Disorder
    Garg, Shruti
    Green, Jonathan
    Leadbitter, Kathy
    Emsley, Richard
    Lehtonen, Annukka
    Evans, D. Gareth
    Huson, Susan M.
    PEDIATRICS, 2013, 132 (06) : E1642 - E1648
  • [10] Neurological comorbidity in children with neurofibromatosis type 1
    Hirabaru, Keiko
    Matsuo, Muneaki
    PEDIATRICS INTERNATIONAL, 2018, 60 (01) : 70 - 75